Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FamiCord AGHAM:V3V -1.58%58 Buyback Yield % is 0.00 as of Jul. 15, 2026. GuruFocus rates HAM:V3V with a GF Score™ of 58/100 and a GF Value™ of €4.28 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 274 Healthcare Providers & Services companies, FamiCord AG ranks worse than 364963.14% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for FamiCord AG's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HAM:V3V vs HCA, THC, DVA: Buyback Yield % Comparison
For the Medical Care Facilities subindustry, FamiCord AG's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
FamiCord AG Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, FamiCord AG's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where FamiCord AG's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FamiCord AG (HAM:V3V) has a Buyback Yield % of 0.00 as of Jul. 15, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on FamiCord AG and its competitors. According to the industry distribution chart, FamiCord AG ranks #999999 out of 274 companies in the Healthcare Providers & Services industry.
Is FamiCord AG's Buyback Yield % too high?
FamiCord AG's current Buyback Yield % is 0.00. Based on the distribution chart, FamiCord AG ranks #999999 out of 274 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, FamiCord AG has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does FamiCord AG's Buyback Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, FamiCord AG ranks #999999 out of 274 companies for Buyback Yield %. This places FamiCord AG in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on FamiCord AG and its competitors. FamiCord AG's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FamiCord AG stock overvalued right now?
Based on GuruFocus' analysis, FamiCord AG (HAM:V3V) is currently considered Modestly Undervalued. The stock's GF Value™ is €4.28, compared to a current price of €3.11 — trading 27.3% below its estimated fair value. The current Buyback Yield % is 0.00. FamiCord AG's overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For FamiCord AG (HAM:V3V), the current Buyback Yield % is 0.00 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is FamiCord AG (HAM:V3V) Overvalued in 2026?
Based on GuruFocus' analysis, FamiCord AG stock appears to be undervalued.
The current stock price of €3.11 is trading 27.3% below its estimated GF Value™ of €4.28.
GuruFocus considers FamiCord AG to be Modestly Undervalued.
Key valuation signals for HAM:V3V:
Buyback Yield %: 0.00
GF Value™: €4.28 vs. price of €3.11 (27.3% below fair value)
No single metric tells the full story. See the HAM:V3V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
FamiCord AG is an umbilical cord blood bank. It supplies cryopreservation and provides logistics for the collection of blood, preparation, and storage of stem cells from umbilical cord blood and tissue. The company is active in the areas of cell and gene therapies and CDMO. It continues to develop from a pure stem cell bank into a more broadly based cell bank that can supply available patients own cells for current and future cell therapies. Its services include stem cells banking, stem cells scientific proof, FamiCord contribution, stem cell applications list, stem cell applications stories, and stem cells banking for society. Its segments include Subgroup Vita 34 and Subgroup PBKM, which generate maximum revenue. It operates in Germany, Poland, Switzerland, and other foreign countries.
58GF Score
Get the complete analysis for HAM:V3V
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:V3V has been successfully added to your 
